Agrupación Estratéxica en Xestión e Produción sustentable de Biorrecursos (BioReDes)
Agrupación estratéxica de I+D+i
Hospital Carlos III
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Carlos III (38)
2017
-
Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study
HIV Medicine, Vol. 18, Núm. 7, pp. 482-489
-
Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach
PLoS ONE, Vol. 12, Núm. 9
2016
-
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013
Journal of Infection, Vol. 72, Núm. 5, pp. 587-596
-
MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression
PLoS ONE, Vol. 11, Núm. 5
2014
-
HIV-2 and HTLV-1 infections in Spain, a non-endemic region
AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159
-
HIV-2 viral tropism influences CD4+ T cell count regardless of viral load
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194
-
Molecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in Spain
AIDS Research and Human Retroviruses, Vol. 30, Núm. 9, pp. 856-862
-
Very late HCV relapse following triple therapy for hepatitis C
Antiviral Therapy
-
X4 tropic viruses are on the rise in recent HIV-1 seroconverters in Spain
AIDS, Vol. 28, Núm. 11, pp. 1603-1609
2013
-
Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B
AIDS, Vol. 27, Núm. 14, pp. 2219-2224
-
Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes
Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 9, pp. 1994-2002
-
Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies
AIDS, Vol. 27, Núm. 1, pp. 81-85
-
Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir
Antiviral Therapy, Vol. 18, Núm. 5, pp. 709-715
2012
-
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy
Retrovirology, Vol. 9
-
Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms
Clinical Infectious Diseases, Vol. 55, Núm. 1
-
Diarrhoeagenic Escherichia coli pathotypes in travellers attending a tropical medicine unit in a Spanish hospital
Journal of Medical Microbiology
-
Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain
Virology Journal, Vol. 9, Núm. 1
2011
-
Drug resistance mutations in patients infected with HIV-2 living in Spain
Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 7, pp. 1484-1488
-
HTLV infection among foreign pregnant women living in Spain
Journal of Clinical Virology, Vol. 52, Núm. 2, pp. 119-122
-
Variabilidad en la determinación del tropismo viral del VIH utilizando diferentes algoritmos genotípicos de interpretación en pacientes VIH-1 infectados con subtipos B versus no-B
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 1, pp. 4-8